←
Lineage Cell Therapeutics1,497 posts
Lineage Cell Therapeutics avatar

Lineage Cell Therapeutics

@LineageCell

A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

◷ Joined August 2012▧ 611 Photos and videos
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Nov 12

$LCTX announces the acquisition of NeuroAirmid Therapeutics, Inc. along with certain worldwide rights to HUNT1 (hNSC01), a pluripotent stem cell derived clinical-stage neural cell therapy program for the treatment of Huntington's Disease. This acquisition adds a third clinical stage asset to Lineage's development pipeline, and aligns with the company's capabilities in cell manufacturing, process development, and scale-up. The HUNT1 program represents the culmination of decades of research led by Leslie Thompson, Ph.D., and is currently being evaluated in the #REGEN4HD clinical study at @UCIrvineHealth. For more details, see here: investor.lineagecell.com/new… #CellTherapy #HuntingtonDisease #RegenerativeMedicine #UniversityofCaliforniaIrvine @CEO_Culley @CIRMNews @HDSA @HuntingtonSG @hdfcures

0:35
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Nov 4

We appreciate @AlexZank from @CFOBrew featuring $LCTX’s CFO Jill Howe, to discuss our approach to advancing promising cell therapy opportunities. Jill shares how we use our AlloSCOPE™ platform to identify therapeutic programs with strong market potential and how we strategically allocate capital to move them forward. For the full article, see here: cfobrew.com/stories/finding-… #CellTherapy #Biotech #RegenerativeMedicine #CFO #LifeSciences

Post attachment
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Oct 29

$LCTX today provided an update on its ReSonanceTM (ANP1) program for #hearingloss. The program is built on our patented AlloSCOPETMmanufacturing platform, and is currently being developed under a research collaboration with William Demant Invest A/S (WDI). Learn more: investor.lineagecell.com/new… @CEO_Culley | #ReplaceAndRestore #CellTherapy #HearingLoss #RegenerativeMedicine @ca_navntoft

0:36
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Oct 26

#CTS2026 replays are now available on demand. $LCTX’s @CEO_Culley was proud to sit alongside presenters from @AbbVie, Oculis, @Valitorbio, @NeurotechPharma, @RecenseM and others, as part of the “From Innovation to Approval: Bringing Novel Treatments to Market” panel, moderated by Pravin U. Dugel, M.D., of @OCUTX. Watch the recorded sessions: ctsretina.org/ #CTSRetina #ClinicalTrials #Ophthalmology #CellTherapy #ReplaceandRestore | @CEO_Culley @ArshadKhanani @CTS_Tahoe

Post attachment
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Oct 15

$LCTX wishes to thank everyone who participated in the Spinal Cord Injury Patient-Focused Drug Development Meeting, especially individuals living with #SCI and care partners who shared their experiences and perspectives. Several themes came through clearly, including how restoring any kind of function, even incremental improvements, can translate into meaningful changes in everyday activities, personal care and quality of life. @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Post attachment
Lineage Cell Therapeutics avatar
Lineage Cell Therapeutics@LineageCell·Oct 13

$LCTX congratulates @ca_navntoft and the Eriksholm Research Center for their review of the current status of cell therapy for restoring auditory nerve function, which highlights the importance of combining #celltherapy with surgical approaches to help people with hearing loss. We look forward to continued progress on our ReSonance® (ANP1) program, an auditory neuronal cell transplant program to treat hearing loss. Read the full article: sciencedirect.com/science/ar… #ReplaceAndRestore #HearingLoss | @CEO_Culley